Followers | 7 |
Posts | 177 |
Boards Moderated | 0 |
Alias Born | 05/05/2013 |
Tuesday, April 01, 2014 2:49:48 AM
Plus, Purdue has NOT had theirs even approved yet. Zogenix most likely will have their drug approved at same time.
Do you have any idea the amount of lawsuits Zogenix is about to win? How many doctors should lose their ability to practice medicine because they can't even use a simple drug comparison chart?
This company is fine. Zohydro is pennies compared to Relday. Relday is finishing Phase 1 clinical trials and will be set to launch in 2016.
FDA made Zohydro go through thorough 18 month review process that has been repetitively and publicly been reaffirmed. Zogenix has license to the IP around Zohydro, AND the abuse deterrent formulation in development. IP alone is worth tens of millions
North Bay Resources Announces Assays up to 5 oz/ton Gold, 1.5 oz/ton Platinum, 0.5 oz/ton Palladium, and 0.5 oz/ton Rhodium at Mt. Vernon Gold Mine, Sierra County, California • NBRI • Oct 4, 2024 9:15 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM
Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • SMX • Oct 3, 2024 7:00 AM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM